New addition to executive team has extensive medical device and finance
MOUNTAIN VIEW, Calif., Oct. 28 /PRNewswire/ -- PolyRemedy, Inc., a manufacturer of point-of-care robotic systems for the fabrication and tracking of customized, nano-material-based wound treatments, has hired Gary Coughlen to serve as the Company's chief financial officer. Coughlen joined the PolyRemedy management team on October 14, 2008, and reports directly to the Company's president and chief executive officer Dan Eckert.
"We are pleased to have Gary on board. Gary is a seasoned professional with more than 20 years of experience in finance, much of it in the medical device setting," Eckert says. "As we prepare to launch revolutionary technology to the wound care market, his experience and proven understanding of the challenges and opportunities facing a rapidly growing medical device company will be a great asset to our team."
As CFO, Coughlen will be responsible for all aspects of PolyRemedy's finance function, including accounting, financial planning and analysis, and internal policy development. In addition, he will oversee other important departments, including facilities, legal, intellectual property and human resources.
"PolyRemedy is an exciting company in an exciting time. I look forward to doing my part in helping the company successfully transform from a start-up, R&D focus to a world class leader offering innovative solutions to the wound care market," Coughlen says.
Coughlen most recently served as CFO and board secretary for Refractec, Inc., a vision technology firm based in Irvine, Ca. While there, he helped raise $42 million in equity capital and $8 million in non-bank debt financing, and he managed the company banking relationship. Coughlen oversaw the company's growth from 3 to 75 employees, and helped transition the company from its R&D stages to commercialization of its product after FDA approval. In addition, he oversaw many legal functions, including patent filing and protection, and established internal departments and policies.
Prior to Refractec, Coughlen served in financial leadership roles at Scieran Technologies, Inc., Laguna Hills, Calif., Precision Capital, Walnut Creek, Calif., and Sierra Capital, Inc., San Francisco. Coughlen also worked in various positions at Concord Assets Group, Boca Raton, Fla., and Security Properties, Inc., and Pricerwaterhouse, both in Seattle, Wash.
Coughlen holds a bachelor's degree in business/accounting from the University of Washington and an MBA from University of California, Berkeley. He is also a certified public accountant.
PolyRemedy, based in Mountain View, Calif., manufactures robotic systems for the fabrication of nano- and micro-fiber wound treatments, on demand and at the point of care. The innovative PolyRemedy system produces customized wound dressings within minutes, measured to fit the wound size and shape and fabricated with the precise material composition necessary to optimally treat the wound. The system also captures and monitors important wound treatment data with the potential to help evaluate costs, refine clinical protocols, and demonstrate evidence-based improvements in wound management.
|SOURCE PolyRemedy, Inc.|
Copyright©2008 PR Newswire.
All rights reserved